Home
Inside Ensoma
Our Science
Pipeline
Careers
News
Contact
Ensoma
Inside Ensoma
About Us
Leadership
Board of Directors
Scientific Advisors
Investors
Our Science
Pipeline
Careers
News
Press Releases
Presentations
Publications
In the News
Contact
In vivo gene editing grabs the spotlight after Intellia triumph, but challenges loom
Post navigation
Previous:
Making stem cell transplants safer
Next:
Searching for the next ‘big hairy goal,’ BlueRock CEO Emile Nuwaysir jumps to in vivo cell therapy startup Ensoma